| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.654 | 29.226 | 23.719 | 23.284 | 0 | 0 | - | - | - | - |
| Total Income - EUR | 68.505 | 29.226 | 23.719 | 23.284 | 0 | 0 | - | - | - | - |
| Total Expenses - EUR | 73.505 | 27.272 | 18.267 | 19.116 | 0 | 0 | - | - | - | - |
| Gross Profit/Loss - EUR | -4.999 | 1.954 | 5.452 | 4.168 | 0 | 0 | - | - | - | - |
| Net Profit/Loss - EUR | -7.013 | 146 | 4.052 | 3.978 | 0 | 0 | - | - | - | - |
| Employees | 5 | 3 | 4 | 0 | 0 | 0 | - | - | - | - |
Check the financial reports for the company - Eladent Rx Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 12.649 | 12.520 | 12.308 | 12.082 | 11.848 | 11.623 | - | - | - | - |
| Current Assets | 13.933 | 12.990 | 13.602 | 13.352 | 13.094 | 12.846 | - | - | - | - |
| Inventories | 3.057 | 3.019 | 3.202 | 3.143 | 3.082 | 3.024 | - | - | - | - |
| Receivables | 168 | 92 | 572 | 562 | 551 | 541 | - | - | - | - |
| Cash | 10.708 | 9.880 | 9.828 | 9.647 | 9.461 | 9.281 | - | - | - | - |
| Shareholders Funds | -21.017 | -20.657 | -16.255 | -15.957 | -15.648 | -15.351 | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | - | - | - | - |
| Debts | 47.600 | 46.167 | 42.165 | 41.391 | 40.590 | 39.820 | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Eladent Rx Srl